162 related articles for article (PubMed ID: 7747265)
1. FDA classification of drugs for teratogenic risk. Teratology Society Public Affairs Committee.
Teratology; 1994 Jun; 49(6):446-7. PubMed ID: 7747265
[TBL] [Abstract][Full Text] [Related]
2. Potential human teratogenicity of frequently prescribed drugs.
Friedman JM; Little BB; Brent RL; Cordero JF; Hanson JW; Shepard TH
Obstet Gynecol; 1990 Apr; 75(4):594-9. PubMed ID: 2314777
[TBL] [Abstract][Full Text] [Related]
3. Report of the Teratology Society Public Affairs Committee symposium on FDA classification of drugs.
Friedman JM
Teratology; 1993 Jul; 48(1):5-6. PubMed ID: 8102499
[No Abstract] [Full Text] [Related]
4. Teratology public affairs committee position paper: Pregnancy labeling for prescription drugs: Ten years later.
Public Affairs Committee of the Teratology Society
Birth Defects Res A Clin Mol Teratol; 2007 Sep; 79(9):627-30. PubMed ID: 17663419
[No Abstract] [Full Text] [Related]
5. Human teratogens: update 2010.
Holmes LB
Birth Defects Res A Clin Mol Teratol; 2011 Jan; 91(1):1-7. PubMed ID: 21254353
[TBL] [Abstract][Full Text] [Related]
6. Food and Drug Administration proposed testing guidelines for developmental toxicity studies. Revision Committee. FDA Guidelines for Developmental Toxicity and Reproduction, Food and Drug Administration.
Collins TF; Sprando RL; Shackelford ME; Hansen DK; Welsh JJ
Regul Toxicol Pharmacol; 1999 Aug; 30(1):39-44. PubMed ID: 10464045
[TBL] [Abstract][Full Text] [Related]
7. Risk classification systems for drug use during pregnancy: are they a reliable source of information?
Addis A; Sharabi S; Bonati M
Drug Saf; 2000 Sep; 23(3):245-53. PubMed ID: 11005706
[TBL] [Abstract][Full Text] [Related]
8. Teratology Public Affairs Committee position paper: maternal obesity and pregnancy.
Scialli AR;
Birth Defects Res A Clin Mol Teratol; 2006 Feb; 76(2):73-7. PubMed ID: 16463272
[TBL] [Abstract][Full Text] [Related]
9. The U.S. Food and Drug Adminstration (FDA) has assigned pregnancy category D to valproate.
Peckman H
N C Med J; 2010; 71(4):396-8. PubMed ID: 21155112
[No Abstract] [Full Text] [Related]
10. Regulatory aspects of teratology: role of the Food and Drug Administration.
Kelsey FO
Teratology; 1982 Apr; 25(2):193-9. PubMed ID: 7048616
[TBL] [Abstract][Full Text] [Related]
11. Nongenital malformations following exposure to progestational drugs: the last chapter of an erroneous allegation.
Brent RL
Birth Defects Res A Clin Mol Teratol; 2005 Nov; 73(11):906-18. PubMed ID: 16206282
[TBL] [Abstract][Full Text] [Related]
12. Classification of drugs for teratogenic risk: an anachronistic way of counseling.
Merlob P; Stahl B
Teratology; 2002 Aug; 66(2):61-2. PubMed ID: 12210007
[No Abstract] [Full Text] [Related]
13. Content and format of labeling for human prescription drugs; pregnancy labeling; public hearing--FDA. Notice of public hearing; request for comments.
Fed Regist; 1997 Jul; 62(147):41061-3. PubMed ID: 10169832
[TBL] [Abstract][Full Text] [Related]
14. Classification of drugs for teratogenic risk: an anachronistic way of counseling: a reply to Merlob And Stahl.
Briggs GG; Freeman RK; Yaffe SJ
Birth Defects Res A Clin Mol Teratol; 2003 Mar; 67(3):207-8. PubMed ID: 12797465
[No Abstract] [Full Text] [Related]
15. Teratology Society Public Affairs Committee position paper: developmental toxicity of endocrine disruptors to humans.
Barlow S; Kavlock RJ; Moore JA; Schantz SL; Sheehan DM; Shuey DL; Lary JM
Teratology; 1999 Dec; 60(6):365-75. PubMed ID: 10590398
[No Abstract] [Full Text] [Related]
16. Principles and practice of teratology for the obstetrician.
Fisher B; Rose NC; Carey JC
Clin Obstet Gynecol; 2008 Mar; 51(1):106-18. PubMed ID: 18303504
[TBL] [Abstract][Full Text] [Related]
17. Pregnancy categories for prescription drugs.
FDA Drug Bull; 1982 Dec; 12(3):24-5. PubMed ID: 7166220
[No Abstract] [Full Text] [Related]
18. Systematic procedure for the classification of proven and potential teratogens for use in research.
Eltonsy S; Martin B; Ferreira E; Blais L
Birth Defects Res A Clin Mol Teratol; 2016 Apr; 106(4):285-97. PubMed ID: 26969841
[TBL] [Abstract][Full Text] [Related]
19. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
20. Obstetric toxicology: teratogens.
Levine M; O'Connor AD
Emerg Med Clin North Am; 2012 Nov; 30(4):977-90. PubMed ID: 23137407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
